Eric Benevich
Corporate Officer/Principal bei NEUROCRINE BIOSCIENCES, INC.
Vermögen: 6 Mio $ am 31.03.2024
Profil
Eric S.
Benevich is currently the Chief Commercial Officer at Neurocrine Biosciences, Inc. Prior to this, he worked as the Vice President of Communications & Marketing at Avanir Pharmaceuticals, Inc. from 2011 to 2015 and as the Senior Director of Marketing at Peninsula Pharmaceuticals, Inc. He completed his undergraduate degree at Washington State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 40 778 ( 0,04% ) | 6 Mio $ | 31.03.2024 |
Aktive Positionen von Eric Benevich
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01.05.2015 |
Ehemalige bekannte Positionen von Eric Benevich
| Unternehmen | Position | Ende |
|---|---|---|
| AVANIR PHARMACEUTICALS INC | Public Communications Contact | 01.01.2015 |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Sales & Marketing | - |
Ausbildung von Eric Benevich
| Washington State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Commercial Services |
